Bahrudin, M.F. et al. 2025. PEMBROLIZUMAB-INDUCED HYPOPHYSITIS WITH CENTRAL DIABETES INSIPIDUS: A RARE IMMUNE-MEDIATED ADVERSE EVENT. Journal of the ASEAN Federation of Endocrine Societies. 40, S1 (May 2025), 29–30. DOI:https://doi.org/10.15605/jafes.040.S1.045.